ZE600322 — Uther Tirzepatide
Vendor COAUther | Tirzepatide, last activity 2 months ago
Vendor certificate from Janoshik reports 99.91% purity; first seen more than three months ago.
5 related batch concerns · 1 mention · summary from 2 sources · updated Aug 15
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 60 mg. Janoshik weighed 67.9 mg — 13% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
18 units
on a U-100 insulin syringe, for 6 mg
Going by the label you would draw 20 units — which from this vial is actually 6.79 mg, not 6 mg.
- The vial holds dry powder: 67.9 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 67.9 mg ÷ 2 ml = 33.9 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 339 mcg.
- Your dose divided by that: 6 mg ÷ 339 mcg = 18 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
Vendor's own certificate shows 99.9% purity
same lot series
This batch is getting unusual attention for its age—about 5.57 times the typical rate
also Uther
This batch is getting unusual attention for its age, with one positive report and one test request in recent discussion
PT-141, same vendor
One concern was raised about this batch
GYC/GGpeps
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
Community Intelligence
- 2 concern reports involving ZE100701
- 1 concern report involving PT10-0528
- 2 concern reports involving PT10-0617
- 1 concern report involving 2026061030
- 2 concern reports involving SN26XY-1-02
Reported against other Uther Tirzepatide batches, not this one.
Also known as: ZE60-0322
Activity
Maxwell: [https://verify.janoshik.com/tests/133977-tir60mg_ZE600322_QH4X2MBN2ZBJ](https://verify.janoshik.com/tests/133977-tir60mg_ZE600322_QH4X2MBN2ZBJ)
View in Telegram →members onlyVendor
Uther